Viela Bio, Inc. (VIE) 2019年年度报告「NASDAQ」.pdf

1、 ANNUAL REPORT 2019 UNITED STATESSECURITIES AND EXCHANGE COMMISSION Washington,D.C.20549 FORM 10-K (Mark One)ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31,2019OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURI

2、TIES EXCHANGE ACT OF 1934FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39067 VIELA BIO,INC.(Exact name of Registrant as specified in its Charter)Delaware82-4187338(State or other jurisdiction ofincorporation or organization)(I.R.S.EmployerIdentification No.)One MedImmune WayFirst Floo

3、r,Area TwoGaithersburg,MD20878(Address of principal executive offices)(Zip Code)Registrants telephone number,including area code:(240)558-0038 Securities registered pursuant to Section 12(b)of the Act:Title of each classTradingSymbol(s)Name of each exchange on which registeredCommon Stock,$0.001 par

4、 value per shareVIEThe Nasdaq Global Select MarketSecurities registered pursuant to Section 12(g)of the Act:None Indicate by check mark if the Registrant is a well-known seasoned issuer,as defined in Rule 405 of the Securities Act.YES NO Indicate by check mark if the Registrant is not required to fi

5、le reports pursuant to Section 13 or 15(d)of the Act.YES NO Indicate by check mark whether the Registrant:(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934 during the preceding 12 months(or for such shorter period that the Registrant was requi

6、red to file such reports),and(2)has been subject to such filing requirements for the past 90 days.YES NO Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T(232.405 of this chapter)duri